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L E T T E R
Management of dermal filler (vascular) complications using
duplex ultrasound
Dear Editor,
The use of dermal fillers using hyaluronic acid injections has emerged
in recent years. Although hyaluronic acid fillers in general have a good
safety profile, the rate of complications will likely increase because of
the expanding use of dermal fillers. These complications may be host
or filler injection related. One of the most feared complications con-
cerns intravascular injections of hyaluronic acid fillers leading to local
skin necrosis, tissue degradation, or blindness.1-3 This topic has been
broadly covered at the latest IMCAS Congress 2020 in Paris. An addi-
tional item in this regard is the use of duplex ultrasound to improve
filler safety.4,5
The application of (duplex) ultrasound in cosmetic dermatology
helps to determine the individual anatomy and map the vascular struc-
tures. When this mapping is done prior to the filler injection, chances
for intravascular injections are minimized. In addition, previously
placed fillers can be identified and complication of fillers accurately
diagnosed. Dermal fillers containing hyaluronic acid are hydrophilic
and show characteristic features. Basically, the ultrasound waves go
through the water-containing filler, and ultrasound gives a black
(anechoic) image when newly placed or a grayish (hypoechoic) view
on the screen when the filler is longstanding.6 In patients with vascu-
lar occlusion, ultrasound color flow (duplex mode) helps to determine
the area with no flow or turbulent flow indicating vessel obstruction.
In Figure 1A, we present one of our cases with occlusion of the
superior labial artery who was managed at our filler complication clinic
by ultrasound-guided (linear probe, 12 MHz) injections of hyaluronidase.
Other protocols for treating vascular occlusions aim to open up the
end arteriae by flooding the affected area with the high dosage of hyal-
uronidase.7 Our protocol targets the causing filler fragments in the larger
arteries with much lower dosages. The instant success of the treatment
can be observed by a restored flowon duplex ultrasound (Figure 1B).
In conclusion, the use of duplex ultrasound may improve the
safety of filler treatments and become an integral part in the current
management arsenal of filler complications. Ultrasound-guided
intralesional delivery of hyaluronidase (Figure 2) is an additional bene-
fit, rendering treatment more precise.
F IGURE 1 A, Duplex ultrasound image of a patient with partial
occlusion of the superior labial artery. Orbicularis oris muscle (white
arrow), teeth (yellow arrow), hyaluronic acid deposit (red arrow). The
yellow asterisk shows part of the superior labial artery with impaired
flow. B, Duplex ultrasound image of a patient with partial occlusion of
the superior labial artery; 13 minutes after treatment with ultrasound-
guided injection hyaluronidase, restoration of the flow was observed
(green asterisk)
F IGURE 2 Duplex ultrasound image of a patient with occlusion of
the supratrochlear artery. Hyaluronic acid deposit (red arrow), bone
(orange arrow). The blue arrow points the needle through which
hyaluronidase was injected in the hyaluronic acid deposit
Received: 9 April 2020 Revised: 17 April 2020 Accepted: 20 April 2020
DOI: 10.1111/dth.13461
Dermatologic Therapy. 2020;e13461. wileyonlinelibrary.com/journal/dth © 2020 Wiley Periodicals LLC. 1 of 2
https://doi.org/10.1111/dth.13461
CONFLICT OF INTEREST




1Department of Dermatology, Leiden University Medical Center, Leiden,
The Netherlands
2Department of Dermatology, Erasmus MC, University Medical Center,
Rotterdam, The Netherlands
Correspondence
Sayed M. Habib, Department of Dermatology, Leiden University
Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.
Email: habib.meelad@gmail.com
ORCID
Sayed M. Habib https://orcid.org/0000-0001-9582-5002
REFERENCES
1. Beleznay K, Carruthers JDA, Humphrey S, Carruthers A, Jones D.
Update on avoiding and treating blindness from fillers: a recent
review of the world literature. Aesthet Surg J. 2019;39(6):
662-674.
2. Park SW, Woo SJ, Park KH, Huh JW, Jung C, Kwon OK. Iatrogenic reti-
nal artery occlusion caused by cosmetic facial filler injections.
Am J Ophthal. 2012;154(4):653-662.e1.
3. DeLorenzi C. Complications of injectable fillers, part 2: vascular compli-
cations. Aesthet Surg J. 2014;34(4):584-600.
4. Schelke LW, Velthuis P, Kadouch J, Swift A. Early ultrasound for diag-
nosis and treatment of vascular adverse events with hyaluronic acid
fillers. J Am Acad Dermatol. 2019. https://doi.org/10.1016/j.jaad.2019.
07.032 [Epub ahead of print].
5. Schelke LW, Decates TS, Velthuis PJ. Ultrasound to improve the safety
of hyaluronic acid filler treatments. J Cosmet Dermatol. 2018;17(6):
1019-1024.
6. Schelke LW, Cassuto D, Velthuis P, Wortsman X. Nomenclature pro-
posal for the sonographic description and reporting of soft tissue
fillers. J Cosmet Dermatol. 2020;19(2):282-288.
7. Urdiales-Galvez F, Delgado NE, Figueiredo V, et al. Treatment of soft
tissue filler complications: expert consensus recommendations. Aes-
thetic Plast Surg. 2018;42(2):498-510.
2 of 2 LETTER
